About Mustafa Hammad — research leadership
Mustafa Hammad, MD, DO, DABIPP, DIPP, CPI, ABRM, FACP, FAAN · United States citizen
Dr. Hammad is a physician–investigator with longitudinal experience as principal investigator across neurology, pain medicine, sleep medicine, pulmonology, psychiatry, immunology, and regenerative medicine. He founded the American Medical Institute (September 2025–present; Stockbridge, Georgia, and Ramallah) and serves as chair of the institutional review board at Global Research Holdings (November 2025–present). He is CPI-certified through the Association of Clinical Research Professionals (August 2016–present).
Academic and institutional roles have included assistant professor of neurology and director of the clinical research unit at Hebron University School of Medicine (July 2022–December 2023), clinical instructor at Birzeit University School of Pharmacy (2025–present), and affiliate leadership for the American Board of Regenerative Medicine regionally (HNC, November 2024–present). Patient and community education continue through daily lectures at HNC and the Ask Dr Hammad channels (TikTok, YouTube, Facebook, Instagram, and LinkedIn in English and Arabic).
Education & postgraduate training
- Fellowship — Emory University: neuromuscular disease, clinical neurophysiology, nerve and muscle neuropathology; added sleep medicine training (July 2004–June 2005).
- Residency — SUNY Stony Brook: combined neurology and internal medicine; assistant clinical instructor (June 1999–June 2004).
- Internship — SUNY Stony Brook internal medicine (June 1999–June 2000).
- MD — University Health Sciences (December 2002–June 2004).
- DO — Lake Erie College of Osteopathic Medicine (August 1995–June 1999), GPA 3.75.
- BS Neuroscience — University of Pittsburgh (August 1992–July 1994), summa cum laude, GPA 3.84.
- Interventional orthopedics fellowship — Interventional Orthopedic Foundation, Denver, CO (July 2017–July 2018): ultrasound- and fluoroscopy-guided orthobiologics.
Board certification (representative)
- American Board of Psychiatry and Neurology (2016–2026 cycle)
- American Board of Regenerative Medicine (2025)
- American Board of Interventional Pain Physicians (2022–2029)
- American Board of Pain Medicine (2019–2027)
- American Board of Sleep Medicine (historical certification window)
- American Board of Clinical Neurophysiology (historical)
- American Board of Obesity Medicine (2019–2029)
- American Board of Internal Medicine (historical)
- United Council for Neurologic Subspecialties — clinical neuromuscular pathology (certification eligible, June 2006).
Fellowships & distinctions
- Fellow of the American Academy of Neurology (FAAN)
- Fellow of the American College of Physicians (FACP)
- Fellow of Interventional Pain Practice (FIPP), World Institute of Pain
Medical licensure (summary)
- Dubai Health Authority professional license (August 2023–March 2027)
- Florida medical license (January 2006–January 2026)
- Georgia medical license (July 2004–May 2020)
- Palestine medical license (September 2014–present)